Device Trial Radar · NCT04182165
Non-Contact Monitoring of Subjects With an Optical Device: A Pilot Usability Study
Last checked: Nov 20, 2026Latest source record: Jul 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
28
Actual
Start
Dec 10, 2019
Primary completion
Feb 10, 2020
Study completion Apr 1, 2020
Sponsor
- Lead sponsor
- ContinUse Biometrics Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 2, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a single-center, prospective study in subjects visiting TASMC for various indications. This study will be divided into two arms: First Arm - Subjects measured by the study staff via the investigational device at the hospital (up to 50 subjects). Second Arm - subjects measuring themselves autonomously with the investigational device at their homes (up to 10 subjects from the first arm). Hence, total number of subjects for the study will be up to N=50. All subjects will be enrolled to the study only after signing an informed consent form. Specifically for the second arm, subjects will undergo proper training by the sponsor's representatives prior to being discharged from the hospital. Training will focus on proper operation of the device, which is also designed for autonomous use in a simple and user-friendly manner. Subjects will be asked to monitor themselves periodically for a duration of up to a week. Ongoing support will be provided by the sponsor upon subject request, either by phone, or on-premise via a dedicated support team. For both arms, device users (either study staff in first arm or subjects in the second arm) will be requested to answer questionnaires in order to assess usability with the investigational device. In both cases, a dedicated sponsor representative will observe the users to gather objective usability data, and aid in the questionnaire filling process.
Conditions
- Usability
Interventions
Gili BioSensor System/ Gili Pro X BioSensor SystemDevice
Usability study
Primary outcomes
What the sponsor says the trial is designed to measure.
- Questionnaires assessed by SUS score and answered by the study staff.Time frame: During the procedure
- Questionnaires assessed by SUS score and answered by the enrolled study subjects.Time frame: During the procedure
- Measurement of vital signs (Heart rate/ Respiratory rate) acquired via the investigational device along with de-identified subject medical data.Time frame: During the procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tel Aviv Sourasky Medical Center (TASMC)
Tel Aviv, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.